Artwork

Content provided by Olivia Clement and BDO USA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Olivia Clement and BDO USA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Knowing When to Call It Quits in Drug Development and Healthcare Innovations

34:28
 
Share
 

Manage episode 262632130 series 2152127
Content provided by Olivia Clement and BDO USA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Olivia Clement and BDO USA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The drug development process is costly, time consuming and laden with risk—with only 1% of drugs making it from pre-clinical all the way to market, according to Pharma Intelligence. To beat these odds, life sciences leaders must know when to continue funding a promising, new product and when to call it quits.

Tune in for insights into:

  • Why a “fast to failure” mentality is key to a successful development pipeline
  • How leaders can redivert organizational resources after ending a program
  • Why drug development failures can ultimately lead to positive outcomes
  continue reading

10 episodes

Artwork
iconShare
 
Manage episode 262632130 series 2152127
Content provided by Olivia Clement and BDO USA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Olivia Clement and BDO USA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The drug development process is costly, time consuming and laden with risk—with only 1% of drugs making it from pre-clinical all the way to market, according to Pharma Intelligence. To beat these odds, life sciences leaders must know when to continue funding a promising, new product and when to call it quits.

Tune in for insights into:

  • Why a “fast to failure” mentality is key to a successful development pipeline
  • How leaders can redivert organizational resources after ending a program
  • Why drug development failures can ultimately lead to positive outcomes
  continue reading

10 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide